Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001465652-16-000007

Options or other derivatives

  • Chief Science/Medical Officer acquired 22,186 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
STRAYER DAVID R Chief Science/Medical Officer 2016-06-30 Grant or award · Incentive Rights +22,186 $0.12 $2,662 22,186 D
Loading xslF345X03/primary_doc.xml…